Ankyrin repeat-rich membrane spanning (ARMS)/Kidins220 scaffold protein regulates neuroblastoma cell proliferation through p21

Mol Cells. 2014 Dec 31;37(12):881-7. doi: 10.14348/molcells.2014.0182. Epub 2014 Nov 10.

Abstract

Cell proliferation is tightly controlled by the cell-cycle regulatory proteins, primarily by cyclins and cyclin-dependent kinases (CDKs) in the G1 phase. The ankyrin repeat-rich membrane spanning (ARMS) scaffold protein, also known as kinase D-interacting substrate of 220 kDa (Kidins 220), has been previously identified as a prominent downstream target of neurotrophin and ephrin receptors. Many studies have reported that ARMS/Kidins220 acts as a major signaling platform in organizing the signaling complex to regulate various cellular responses in the nervous and vascular systems. However, the role of ARMS/Kidins220 in cell proliferation and cell-cycle progression has never been investigated. Here we report that knockdown of ARMS/Kidins220 inhibits mouse neuroblastoma cell proliferation by inducing slowdown of cell cycle in the G1 phase. This effect is mediated by the upregulation of a CDK inhibitor p21, which causes the decrease in cyclin D1 and CDK4 protein levels and subsequent reduction of pRb hyperphosphorylation. Our results suggest a new role of ARMS/Kidins220 as a signaling platform to regulate tumor cell proliferation in response to the extracellular stimuli.

Keywords: cell cycle; cyclin; neurotrophin; proliferation; scaffold protein.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Cell Proliferation*
  • Cyclin D1
  • Cyclin-Dependent Kinase 4
  • Gene Expression Regulation, Neoplastic
  • Gene Knockdown Techniques
  • Membrane Proteins / genetics*
  • Membrane Proteins / metabolism*
  • Mice
  • Neuroblastoma / metabolism*
  • Neuroblastoma / pathology*
  • Phosphorylation
  • Signal Transduction

Substances

  • Ccnd1 protein, mouse
  • Kidins220 protein, mouse
  • Membrane Proteins
  • Cyclin D1
  • Cdk4 protein, mouse
  • Cyclin-Dependent Kinase 4